The global market for Cartilage Degeneration Therapy is estimated at US$12.8 Billion in 2023 and is projected to reach US$18.8 Billion by 2030, growing at a CAGR of 5.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Cartilage Degeneration Therapy Market]( "Cartilage Degeneration Therapy Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Joint Replacements segment, which is expected to reach US$7 Billion by 2030 with a CAGR of a 6.2%. The Chondroplasty segment is also set to grow at 5.8% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $3.9 Billion in 2023, and China, forecasted to grow at an impressive 5.3% CAGR to reach $3.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Cartilage Degeneration Therapy Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Cartilage Degeneration Therapy Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Cartilage Degeneration Therapy Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as B. Braun Melsungen AG, DePuy Synthes, Smith & Nephew PLC, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 42 Featured):
- B. Braun Melsungen AG
- DePuy Synthes
- Smith & Nephew PLC
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Cartilage Degeneration Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 2: World Historic Review for Cartilage Degeneration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 3: World 16-Year Perspective for Cartilage Degeneration Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Joint Replacements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 5: World Historic Review for Joint Replacements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 6: World 16-Year Perspective for Joint Replacements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Chondroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 8: World Historic Review for Chondroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 9: World 16-Year Perspective for Chondroplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Osteochondral Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 11: World Historic Review for Osteochondral Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 12: World 16-Year Perspective for Osteochondral Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Microfracture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 14: World Historic Review for Microfracture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 15: World 16-Year Perspective for Microfracture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Meniscus Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 17: World Historic Review for Meniscus Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 18: World 16-Year Perspective for Meniscus Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Cell based Cartilage Resurfacing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 20: World Historic Review for Cell based Cartilage Resurfacing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 21: World 16-Year Perspective for Cell based Cartilage Resurfacing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Autologus Chondrocyte Implantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 23: World Historic Review for Autologus Chondrocyte Implantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 24: World 16-Year Perspective for Autologus Chondrocyte Implantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 25: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 26: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 27: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 28: World Recent Past, Current & Future Analysis for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 29: World Historic Review for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 30: World 16-Year Perspective for Knee by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 31: World Recent Past, Current & Future Analysis for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 32: World Historic Review for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 33: World 16-Year Perspective for Hip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 34: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 35: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 36: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 37: World Cartilage Degeneration Therapy Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
UNITED STATES
- Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 38: USA Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 39: USA Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 40: USA 16-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2014, 2024 & 2030
- Table 41: USA Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 42: USA Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 43: USA 16-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2014, 2024 & 2030
CANADA
- Table 44: Canada Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 45: Canada Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 46: Canada 16-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2014, 2024 & 2030
- Table 47: Canada Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 48: Canada Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 49: Canada 16-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2014, 2024 & 2030
JAPAN
- Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 50: Japan Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 51: Japan Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 52: Japan 16-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2014, 2024 & 2030
- Table 53: Japan Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 54: Japan Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 55: Japan 16-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2014, 2024 & 2030
CHINA
- Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 56: China Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 57: China Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 58: China 16-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2014, 2024 & 2030
- Table 59: China Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 60: China Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 61: China 16-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2014, 2024 & 2030
EUROPE
- Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 62: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 63: Europe Historic Review for Cartilage Degeneration Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 64: Europe 16-Year Perspective for Cartilage Degeneration Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 65: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 66: Europe Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 67: Europe 16-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2014, 2024 & 2030
- Table 68: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 69: Europe Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 70: Europe 16-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2014, 2024 & 2030
FRANCE
- Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 71: France Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 72: France Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 73: France 16-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2014, 2024 & 2030
- Table 74: France Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 75: France Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 76: France 16-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2014, 2024 & 2030
GERMANY
- Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 77: Germany Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 78: Germany Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 79: Germany 16-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2014, 2024 & 2030
- Table 80: Germany Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 81: Germany Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 82: Germany 16-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2014, 2024 & 2030
ITALY
- Table 83: Italy Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 84: Italy Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 85: Italy 16-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2014, 2024 & 2030
- Table 86: Italy Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 87: Italy Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 88: Italy 16-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 89: UK Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 90: UK Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 91: UK 16-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2014, 2024 & 2030
- Table 92: UK Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 93: UK Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 94: UK 16-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 95: Rest of Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 96: Rest of Europe Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 97: Rest of Europe 16-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2014, 2024 & 2030
- Table 98: Rest of Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 99: Rest of Europe Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 100: Rest of Europe 16-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 102: Asia-Pacific Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 103: Asia-Pacific 16-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2014, 2024 & 2030
- Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 105: Asia-Pacific Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 106: Asia-Pacific 16-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2014, 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- B. Braun Melsungen AG
- DePuy Synthes
- Smith & Nephew PLC
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | October 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 12.8 Billion |
| Forecasted Market Value ( USD | $ 18.8 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
